Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac application of embryonic stem cells.

Yong-Fu Xiao1

  • 1Stem Cell Research Laboratory, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. yxiao@bidmc.harvard.edu

Sheng Li Xue Bao : [Acta Physiologica Sinica]
|October 21, 2003
PubMed
Summary

Embryonic stem cells (ESCs) show promise for regenerating heart tissue after myocardial infarction. Animal studies demonstrate ESC transplantation can repair injured myocardium and improve cardiac function, offering hope for heart failure therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunomodulator FTY720 improves glucose homeostasis and diabetic complications by rejuvenation of β-cell function in nonhuman primate model of diabetes.

Fundamental & clinical pharmacology·2022
Same author

Effects of mixed meal tolerance test on gastric emptying, glucose and lipid homeostasis in obese nonhuman primates.

Scientific reports·2021
Same author

Diastolic dysfunction and impaired cardiac output reserve in dysmetabolic nonhuman primate with proteinuria.

Journal of diabetes and its complications·2021
Same author

Carbon tetrachloride (CCl<sub>4</sub>) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF).

BMC gastroenterology·2020
Same author

Comparison of Continuous Glucose Monitoring between Dexcom G4 Platinum and HD-XG Systems in Nonhuman Primates (Macaca Fascicularis).

Scientific reports·2017
Same author

The time course of erythrocyte membrane fatty acid concentrations during and after treatment of non-human primates with increasing doses of an omega-3 rich phospholipid preparation derived from krill-oil.

Lipids in health and disease·2017

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Stem Cell Biology

Background:

  • Myocardial infarction (MI) leads to cardiomyocyte death, replaced by non-contractile scar tissue, often causing heart failure.
  • Repairing injured myocardium and improving cardiac function after MI is a significant therapeutic challenge.
  • Stem cell transplantation is being explored experimentally to replace lost myocardium.

Purpose of the Study:

  • To summarize recent experimental findings on embryonic stem cell (ESC) transplantation in animal models of myocardial injury.
  • To highlight research progress in using ESCs and their derivatives for cardiac regeneration.
  • To assess the potential of ESCs for cell therapy targeting functional myocardium regeneration.

Main Methods:

  • Review of recent animal studies involving intramyocardial transplantation of ESCs or their differentiated cardiac-like cells.

Related Experiment Videos

  • Analysis of studies using intravenous infusion of ESCs in viral myocarditis models.
  • Examination of in vitro development and characterization of cardiomyocytes from human ESCs.

    • Main Results:

    • Intramyocardial ESC transplantation regenerated injured myocardium and improved heart function in infarcted animal models.
    • Intravenous ESC infusion increased survival rates and attenuated myocardial injury in viral myocarditic mice.
    • Development of cardiomyocytes from human ESCs in vitro has been reported.

    Conclusions:

    • ESCs are a potential valuable resource for cell therapy due to their proliferative and differentiation capacities.
    • ESC transplantation demonstrates efficacy in regenerating cardiac tissue and improving function in experimental models.
    • Significant ethical, political, and scientific barriers must be addressed for clinical application of human ESCs in cardiac disease.